These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4651368)

  • 1. [Long-term heparinization in the treatment of chronic renal failure with intermittent hemodialysis].
    Kiriakov Z; Otsetova S
    Khirurgiia (Sofiia); 1972; 25(4):357-9. PubMed ID: 4651368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of hemodialysis, heparin and protamin on the pre-beta fraction of lipoproteins in patients with chronic kidney failure].
    Koslík S; Takác M; Koslíkova G
    Z Gesamte Inn Med; 1977 Dec; 32(23):658-61. PubMed ID: 204117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in renal failure.
    Hall AV; Clark WF; Parbtani A
    Clin Nephrol; 1992 Aug; 38(2):86-9. PubMed ID: 1516285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Need-adapted heparinization in hemodialysis].
    Vogel G; Kopp KF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1563-5. PubMed ID: 1030047
    [No Abstract]   [Full Text] [Related]  

  • 6. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B; Blombäck M; Johnsson H; Lins LE
    Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with minimal intermittent heparinization in chronic dialysis patients].
    Kovác A; Hünicke G; Bierwisch H
    Z Urol Nephrol; 1980 May; 73(5):353-9. PubMed ID: 7456802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subcutaneous calcium heparin in hemodialysis (author's transl)].
    Molinari ML; Zoni G
    Haematologica; 1975 Dec; 60(4):466-76. PubMed ID: 816716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation in patients with chronic renal failure].
    Niksic L; Saudan P; Boehlen F
    Rev Med Suisse; 2006 Mar; 2(55):586-8, 590-2. PubMed ID: 16562602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD).
    Dubrow A; Flamenbaum W; Mittman N; Hall J; Zinn J
    Trans Am Soc Artif Intern Organs; 1984; 30():52-4. PubMed ID: 6398552
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis].
    Noguchi M; Izumi K; Deguchi K; Endoh T; Tsuda M; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():177-83. PubMed ID: 2172594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
    Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
    Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin usage in chronic hemodialysis.
    Lewis LM
    Nephrol Nurse; 1981; 3(2):33, 47. PubMed ID: 6907680
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of heparin on lipid metabolism in patients with chronic renal failure treated with hemodialysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Aug; 32(34):1337-40. PubMed ID: 905179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prothrombin time in long-term hemodialyzed patients. The effect of a single hemodialysis, heparin, protamine and vitamin K].
    Koslík S; Ponist J; Takác M; Lapsanská I
    Cas Lek Cesk; 1983 Feb; 122(5):139-42. PubMed ID: 6831493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.